Central Nervous System (CNS)

The effects of long term exposure to blue light on a range of behavioural parameters in mice, such as anxiety, locomotor activity, cognition, and sleep patterns is explored in this study. Male mice (30) were subjected to 4 or 8 h of exposure to the blue light every day for two weeks while the control group was kept under normal lighting. To understand anxiety, motor functions, cognitive flexibility, and circadian rhythms, the Open Field Test, Elevated Plus Maze, Y-Maze, and Wheel Running Test was carried out to assess behavioural attributes. The outcomes proved that long-term exposure to blue light caused strong decreases in the locomotor activity and cognitive performance and caused the increase in the anxiety-like behaviours and the interruption of the normal sleep-wake cycles. The results indicate that chronic exposure to blue light may be harmful to both mental and physical health, and may have ramifications for the body particularly with regards to contemporary lifestyles that are reliant on digital-screen and artificial light. This study implies necessity of conducting further researches on long-term influence of blue light on behaviour and the necessity of managing one’s exposure to avoid possible risks.

Patients who are suffering from illnesses that influence the central nervous system (CNS) struggle with getting medicine because of the presence of two barriers: the blood-cerebrospinal fluid boundary and the intrinsic blood-cerebrum obastruction (BBB). Both of these barriers make it hard to safely give prescription. There are various neurological conditions that are routinely perceived, including Alzheimer's disease, frontotemporal dementia, amyotrophic parallel sclerosis, Parkinson's disease, and Huntington's disease, to give some examples. In addition to these disorders, there are some that can affect the neurological system. Nanotechnology in drug conveyance systems is one therapy strategy that has the possibility to be powerful in the treatment of specific ailments. This is because nanotechnology has the capacity to control the distribution of drugs. To conquer the problems that have been presented and making progress in the conveyance of medications to the central nervous system, various approaches have been created to be successful. This research was completed determined to cast light on late advancements in the field of nanotherapeutics research and the possible consequences of these advancements in the treatment of illnesses that disable the central nervous system. The research was completed with the target of shedding light on these advancements. Another subject that is investigated is the challenges that are experienced while endeavoring to bring nanomedicine from the research facility to the bedside with the end goal of clinical application.